Richard Scott, chief investment officer of Hawksmoor, is backing healthcare as a sector to outperform and has added three preferred names to his multi-manager funds.
Polar Capital has hired Deane Donnigan and David Pinniger to work within its healthcare team in an effort to increase the range of the group's products in this area.
Schroders is to change the name of its £74m Medical Discovery fund as it brings the fund in line with competitors.
Investors should snap up bargains in US healthcare, technology and financial stocks which offer better value than any time over the past 60 years, Legg Mason's chief investment officer Sam Peters has said.
Gareth Powell, fund manager - healthcare at Polar Capital, analyses the impact of the Affordable Care Act.
Neil Woodford's £20bn income portfolios are set for a boost after small-cap healthcare stock Proximagen was subject to an agreed bid, at more than twice the share price he paid.
Neptune UK Mid Cap fund manager Mark Martin looks at the prospects for companies in the out of favour pharmaceutical industry.
Neil Woodford's love of pharmaceutical companies has been well publicised over the past few years, but the income investor has been particularly excited about the prospects of a company using pieces of pig to regrow human tissue.